Pentwater Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Pentwater Capital Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-978,700	Closed	-$47M	–	191
2020 Q1	$47M	Buy	978,700 +808,700	+476%	+$37.6M	0.78%	33
2019 Q4	$7.98M	Buy	+170,000	New	+$7.51M	0.13%	63

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Pentwater Capital Management's RARX Position: Q2 2020 in Review

Pentwater Capital Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 978,700 shares — an estimated $47M sold.

Pentwater Capital Management first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $47M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Pentwater Capital Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Pentwater Capital Management sold 978,700 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $47M.
Pentwater Capital Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Pentwater Capital Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $47M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Pentwater Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.